Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
National Institutes of Health
- Opportunity #
- PAR-25-247
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.866
- Status
- posted
- Posted
- Dec 13, 2024
- Closes
- Sep 25, 2026
- Funding instrument
- Grant
- Category
- Health
- Cost sharing required
- No
Who can apply
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- •County governments
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
- •Public housing authorities/Indian housing authorities
- •For profit organizations other than small businesses
- •Native American tribal organizations (other than Federally recognized tribal governments)
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- •Special district governments
- •Independent school districts
- •Small businesses
- •City or township governments
- •Public and State controlled institutions of higher education
- •State governments
- •Private institutions of higher education
- •Native American tribal governments (Federally recognized)
Synopsis
The specific purpose of this Notice of Funding Opportunity (NOFO) is to promote the development of a diverse, interdisciplinary workforce needed to conduct translational research on Alzheimer's disease and Alzheimer's-related dementias from target discovery through clinical development. This NOFO will support institutional training programs for predoctoral and postdoctoral level researchers with diverse educational backgrounds (i.e., basic biology, translational and clinical research, data science). The program invites eligible institutions to develop interdisciplinary training programs that will provide trainees with the knowledge and skills in data science, disease biology, behavioral research, and traditional and emerging drug discovery disciplines necessary to conduct rigorous and cutting-edge basic, translational, and clinical research for AD/ADRD.
Contact
National Institutes of Health · grantsinfo@nih.gov